September 25, 2011
Takeda Pharmaceutical’s type 2 diabetes treatment Liovel, an oral fixed-dose combination of the company’s type 2 diabetes treatments Actos (pioglitazone) and Nesina (alogliptin), was added to the NHI drug price list on September 12. The peak sales forecast is ¥23.6...read more